Related Experiment Video
Updated: Aug 22, 2025

07:35
A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
Published on: October 13, 2023
1.7K
MSF-UBRW: An Improved Unbalanced Bi-Random Walk Method to Infer Human lncRNA-Disease Associations
Lingyun Dai1, Rong Zhu1, Jinxing Liu1
1School of Computer Science, Qufu Normal University, Rizhao 276826, China.
Genes
|November 11, 2022
Summary
This study introduces MSF-UBRW, a new computational method to identify long non-coding RNA-disease associations (LDAs). The method effectively predicts potential LDAs, aiding disease research.
Area of Science:
- Genomics
- Bioinformatics
- Computational Biology
Background:
- Long non-coding RNAs (lncRNAs) play crucial roles in human diseases.
- Accurate identification of lncRNA-disease associations (LDAs) is vital for understanding disease mechanisms.
- Existing computational models have limitations in discovering novel LDAs.
Purpose of the Study:
- To develop a novel computational method, MSF-UBRW, for predicting potential lncRNA-disease associations (LDAs).
- To enhance the accuracy and reliability of LDA prediction by integrating multiple similarity measures.
- To validate the method's effectiveness through rigorous cross-validation and case studies.
Main Methods:
- A novel method, MSF-UBRW (multiple similarities fusion based on unbalanced bi-random walk), was designed.
- Linear fusion of functional similarity and Gaussian Interaction Profile kernel similarity for lncRNAs and diseases.
- Prediction of potential LDAs using an unbalanced bi-random walk approach.
- Validation using leave-one-out cross-validation (LOOCV) and 5-fold cross-validation (5-fold CV).
Main Results:
- The MSF-UBRW method demonstrated high prediction accuracy.
- Achieved an Area Under the Curve (AUC) of 0.9391 in LOOCV.
- Achieved an AUC of 0.9183 (±0.0054) in 5-fold CV, confirming reliable performance.
- Case studies successfully identified new LDAs for three common diseases.
Conclusions:
- MSF-UBRW effectively predicts novel lncRNA-disease associations.
- The integration of multiple similarities significantly improves prediction performance.
- MSF-UBRW offers a reliable tool for advancing research in lncRNA and disease studies.
Related Concept Videos
lncRNA - Long Non-coding RNAs
8.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
Genome-wide Association Studies-GWAS
14.0K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.0K
Non-LTR Retrotransposons
11.7K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.7K

